Literature DB >> 21890841

Investigation of thyroid dysfunction is more likely in patients with high psychological morbidity.

H Bould1, V Panicker, D Kessler, C Durant, G Lewis, C Dayan, J Evans.   

Abstract

BACKGROUND: Mild or subclinical hypothyroidism [raised thyroid-stimulating hormone (TSH) but normal free thyroxine (T4)] affects 5-10% of adults. Symptoms are non-specific and TSH levels are needed for diagnosis.
OBJECTIVES: We explore the relationship between thyroid function and psychological distress and investigate the usefulness of an expert-designed Thyroid Symptom Questionnaire (TSQ) in identifying hypothyroidism.
METHODS: DEPTH (DEPression and THyroid) is a cross-sectional study of 325 patients recruited from general practices in Bristol, for whom thyroid function tests were requested by the GP. Subjects completed the TSQ, General Health Questionnaire (GHQ-12) and Patient Health Questionnaire (PHQ) and had blood tests for TSH and free T4.
RESULTS: The mean age was 45.7 years; 252 subjects (78%) were female; median TSH was 1.6. Psychological morbidity in this population is high: 54.2% have a GHQ-12 score >3, indicating psychological distress. We found no relationship between TSH and psychological distress [adjusted odds ratio 1.02 (95% confidence interval 0.91-1.13), P = 0.78]. The prevalence of hypothyroidism was 6.2% (95% confidence interval 3.8-9.5%). We found no evidence of an unadjusted association between TSQ score and subclinical hypothyroidism [adjusted odds ratio of 1.09 (95% confidence interval 0.95-1.24), P = 0.23].
CONCLUSIONS: Those referred for thyroid function tests, although no more likely than others to have hypothyroidism, have high rates of psychological distress. When mild (subclinical) hypothyroidism is detected in patients with psychological distress, it is important that GPs are aware that this is likely to be coincidental rather than causal and offer appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21890841     DOI: 10.1093/fampra/cmr059

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  8 in total

Review 1.  Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level.

Authors:  Jacqueline Jonklaas
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-10       Impact factor: 3.243

2.  An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction.

Authors:  Sarah J Peterson; Anne R Cappola; M Regina Castro; Colin M Dayan; Alan P Farwell; James V Hennessey; Peter A Kopp; Douglas S Ross; Mary H Samuels; Anna M Sawka; Peter N Taylor; Jacqueline Jonklaas; Antonio C Bianco
Journal:  Thyroid       Date:  2018-04-05       Impact factor: 6.568

3.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 4.  Hypothyroidism and depression.

Authors:  Colin M Dayan; Vijay Panicker
Journal:  Eur Thyroid J       Date:  2013-08-27

Review 5.  Global epidemiology of hyperthyroidism and hypothyroidism.

Authors:  Peter N Taylor; Diana Albrecht; Anna Scholz; Gala Gutierrez-Buey; John H Lazarus; Colin M Dayan; Onyebuchi E Okosieme
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

6.  Time for a reassessment of the treatment of hypothyroidism.

Authors:  John E M Midgley; Anthony D Toft; Rolf Larisch; Johannes W Dietrich; Rudolf Hoermann
Journal:  BMC Endocr Disord       Date:  2019-04-18       Impact factor: 2.763

Review 7.  Combination Thyroid Hormone Replacement; Knowns and Unknowns.

Authors:  Peter N Taylor; Vinay Eligar; Ilaria Muller; Anna Scholz; Colin Dayan; Onyebuchi Okosieme
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-22       Impact factor: 5.555

Review 8.  Thyroxine and treatment of hypothyroidism: seven decades of experience.

Authors:  Roselyn Cristelle I Mateo; James V Hennessey
Journal:  Endocrine       Date:  2019-07-18       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.